A Dipeptidyl Peptidase–4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E–Deficient Mice

Study Questions:

What is the effect of dipeptidyl peptidase-4 (DPP-4) inhibition on endothelial function and atherosclerosis in mice?